We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Painless Esthetic Skin Treatments

By HospiMedica staff writers
Posted on 02 Feb 2006
A new aesthetic skin treatment combines broadband light with pneumatic energy to deliver more efficient photons to dermal and epidermal targets, and with significantly less pain.

The Aesthera PPx, manufactured by Aesthera (Pleasanton, CA, USA), is a stand-alone multi-application system where the technology driving the system is embedded in microchips. More...
Pnemopneumatic therapy (PPx) uses personalized single-use disposable tips specifically designed for unique body parts, which are individually customized for different applications. The therapy is indicated for treating sun-damaged and aging skin, including brown spots, redness, and broken capillaries, as well as unwanted hair and unsightly veins. The system has been cleared by the U.S. Food and Drug Administration (FDA).

Through a proprietary sequence of light and pneumatic energy, four to five times less energy is required for effective treatments. Using a pneumatic sequence, the treatment area is stretched to reduce the concentration of absorptive chromophores of blood and melanin. When light is then applied to the skin, the elevated targets, reduced melanin, and blanched dermal vessels allow four to five times more photons to impact the target.

Under negative pressure in the handpiece, liquid on the skin's surface extracts large amounts of heat from the tissue and evaporates it at protective temperatures, creating a safe environment of continual cooling that provides protection to the skin. This cooling mechanism does not require external cooling agents such as cryogen sprays, gels, or costly internal cooling systems, and patients do not need to undergo time-consuming pre-treatment procedures such as applying topical numbing agents or cooling gels.

"With traditional lasers and light based systems, there is a very fine line between effectiveness and collateral damage. Photopneumatic therapy significantly widens this gap by dramatically increasing photon absorption, reducing the overall energy required and widening the otherwise very narrow safety margins,” said Vic Narurkar, M.D., director and founder of the Bay Area Laser Institute in San Francisco (CA, USA).




Related Links:
Aesthera

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammography System (Analog)
MAM VENUS
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.